Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5139]
News [14910]
Articles [105]
Editorials [3]
Conferences [246]
elearning [21]
miR 371-373 and miR 302 cluster expression in body fluids as potential...
Dr Matthew Murray - Cambridge Cancer Centre, UK
miR 371-373 and miR 302 cluster expression in body fluids as potential biomarkers of malignant germ cell tumours ( Dr Matthew Murray - Cambridge Cancer Centre, UK )
29 May 2013
Global microRNA profiles in extracranial and intracranial malignant germ cell...
Dr Matthew Murray - Cambridge Cancer Centre, UK
Global microRNA profiles in extracranial and intracranial malignant germ cell tumours ( Dr Matthew Murray - Cambridge Cancer Centre, UK )
29 May 2013
Intracranial germinoma mimicking multiple sclerosis
Dr David Sumerauer - Charles University, Second Medical School, University...
Intracranial germinoma mimicking multiple sclerosis ( Dr David Sumerauer - Charles University, Second Medical School, University Hospital Motol, Prague, Czech Republic )
29 May 2013
Blood biopsies for tumour cell detection
Dr Alberto Bardelli - University of Torino Medical School, Turin, Italy
Blood biopsies for tumour cell detection ( Dr Alberto Bardelli - University of Torino Medical School, Turin, Italy )
29 May 2013
Surgery in mesothelioma
Dr Paul Baas - Netherlands Cancer Institute, Amsterdam
Surgery in mesothelioma ( Dr Paul Baas - Netherlands Cancer Institute, Amsterdam )
16 May 2013
Advances and perspectives on biomarkers
Dr Nicola Normanno - Institute Fondazione Pascale, Naples, Italy
Advances and perspectives on biomarkers ( Dr Nicola Normanno - Institute Fondazione Pascale, Naples, Italy )
16 May 2013
Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials
Dr Anna Vivancos - Vall d´Hebron Institute of Oncology, Barcelona, Spain
Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials ( Dr Anna Vivancos - Vall d´Hebron Institute of Oncology, Barcelona, Spain )
16 May 2013
Integrating breast cancer genomics and proteomics
Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA
Integrating breast cancer genomics and proteomics ( Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA )
15 May 2013
Genetic and clinical factors best for predicting late recurrence in oestrogen...
Dr Ivana Sestak - Queen Mary University of London, UK
Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer ( Dr Ivana Sestak - Queen Mary University of London, UK )
15 May 2013
CD4 T cells in extensively inflitrated breast cancer signal organised immune...
Dr Karen Willard-Gallo - Université Libre de Bruxelles, Brussels, Belgium
CD4 T cells in extensively inflitrated breast cancer signal organised immune response and predict survival ( Dr Karen Willard-Gallo - Université Libre de Bruxelles, Brussels, Belgium )
15 May 2013
How do we design trials that improve outcome?
Dr Lisa Carey - University of North Carolina, Chapel Hill, USA
How do we design trials that improve outcome? ( Dr Lisa Carey - University of North Carolina, Chapel Hill, USA )
15 May 2013
Breast cancer heterogeneity no barrier to predictive testing
Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland
Breast cancer heterogeneity no barrier to predictive testing ( Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland )
15 May 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation